AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimicet-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Affix Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimicet-M 1 Tablet PR

Diabetic patients may find relief with the anti-diabetic medication, GlucoTwin. This dual-action formulation is indicated for adult-onset type 2 diabetes, effectively managing blood glucose. Administer GlucoTwin with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, GlucoTwin is part of a comprehensive program encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle adjustments significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and always carry a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. GlucoTwin is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any heart conditions before starting treatment. Pregnant or breastfeeding individuals should seek medical counsel prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests, may be recommended by your physician.

Uses of Glimicet-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimicet-M 1 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for usage guidelines. Take one Glimicet-M tablet (PR) with a meal.

Common Side effects of Glimicet-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimicet-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Glimicet-M 1 Tablet PR with a meal.

How Glimicet-M 1 Tablet PR works:

Glimicet-M 1 Tablet PR combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimicet-M 1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimicet-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Glimicet-M 1 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimicet-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimicet-M 1 Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimicet-M 1 Tablet PR cautiously, potentially requiring dosage modification. Severe hepatic disease contraindicates its use; low initial doses are generally recommended for those with mild to moderate liver disease. Physician consultation is advised.

What if you forget to take Glimicet-M 1 Tablet PR :

Should you forget to take a Glimicet-M 1 Tablet PR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glimicet-M 1 Tablet PR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Glimicet-M 1 Tablet PR

Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medicine. Prevent access by children, pets, and others.
Indeed, Glimicet-M 1 Tablet PR carries a risk of lactic acidosis, a serious medical condition resulting from excessive blood lactate. Also termed MALA (Metformin-associated lactic acidosis), this rare but potentially dangerous adverse effect is particularly concerning for individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia warrant immediate discontinuation of Glimicet-M 1 Tablet PR and prompt medical attention.
Glimicet-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used alongside a healthy diet and regular physical activity. Glimepiride's action involves stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This dual-drug formulation is unsuitable for treating type 1 diabetes.
Taking Glimicet-M 1 Tablet PR may cause frequent side effects such as low blood sugar, changes in taste perception, queasiness, abdominal discomfort, loose stools, and headaches. Rare but potentially severe adverse reactions include lactic acidosis. Prolonged treatment might also result in a deficiency of vitamin B12.
Indeed, prolonged Glimicet-M 1 Tablet PR administration can lead to Vitamin B12 insufficiency. This medication impairs Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Prophylactic supplemental Vitamin B12, at a minimum of once annually, is recommended by some investigators to mitigate these risks.
Indeed, taking Glimicet-M 1 Tablet PR can lead to hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may include nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Combining Glimicet-M 1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimicet-M 1 Tablet PR
66
MRP 80
17% off